Westside Investment Management, Inc. - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2023$281,227
-26.7%
41,540
-1.7%
0.08%
-25.0%
Q2 2023$383,539
+60.0%
42,240
+13.8%
0.11%
+54.3%
Q1 2023$239,703
+124745.3%
37,105
+22.1%
0.07%
Q4 2022$192
-99.9%
30,390
+0.5%
0.00%
Q3 2022$187,000
-29.7%
30,240
+0.3%
0.00%
-100.0%
Q2 2022$266,000
+19.8%
30,140
+14.2%
0.00%
Q1 2022$222,000
+181.0%
26,390
+238.3%
0.00%
Q4 2021$79,0007,8000.00%
Other shareholders
INMUNE BIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 275,000$5,341,0002.77%
Fermata Advisors, LLC 12,830$249,0000.11%
DG Capital Management, LLC 20,000$388,0000.08%
YorkBridge Wealth Partners, LLC 10,369$201,0000.05%
Ikarian Capital, LLC 26,632$517,0000.04%
Financial Advocates Investment Management 16,667$324,0000.02%
Janney Montgomery Scott LLC 99,323$1,929,0000.01%
Belvedere Trading LLC 16,177$302,0000.01%
FNY Investment Advisers, LLC 800$15,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 17,200$334,0000.01%
View complete list of INMUNE BIO INC shareholders